NCT04353752View on ClinicalTrials.gov

Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Cystic Fibrosis
Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

National Jewish Health

OTHER

NCT04353752 - Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs | Biotech Hunter | Biotech Hunter